Print previewpersonal data approved: 2023. IX. 13. Publications |
2022
 from data base, 2023. IX. 13. |
Tímár J., Ladányi A.: Molecular Pathology of Skin Melanoma: Epidemiology, Differential Diagnostics, Prognosis and Therapy Prediction, INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES 23: (10) 5384 type of document: Journal paper/Review paper number of independent citations: 6 language: English URL |
2020
 from data base, 2023. IX. 13. |
Ladányi Andrea, Tímár József: Immunologic and immunogenomic aspects of tumor progression, SEMINARS IN CANCER BIOLOGY 60: pp. 249-261. type of document: Journal paper/Review paper number of independent citations: 20 language: English URL |
2020
 from data base, 2023. IX. 13. |
Ladányi Andrea, Papp Eszter, Mohos Anita, Balatoni Tímea, Liszkay Gabriella, Oláh Judit, Varga Anita, Lengyel Zsuzsanna, Emri Gabriella, Ferrone Soldano: Role of the anatomic site in the association of HLA class I antigen expression level in metastases with clinical response to ipilimumab therapy in patients with melanoma, JOURNAL FOR IMMUNOTHERAPY OF CANCER 8: (1) e000209 type of document: number of independent citations: 6 language: English URL |
2019
 from data base, 2023. IX. 13. |
Ladányi Andrea, Kapuvári Bence, Papp Eszter, Tóth Erika, Lövey József, Horváth Katalin, Gődény Mária, Remenár Éva: Local immune parameters as potential predictive markers in head and neck squamous cell carcinoma patients receiving induction chemotherapy and cetuximab., HEAD AND NECK : JOURNAL FOR THE SCIENCES AND SPECIALTIES OF THE HEAD AND NECK 41: (5) pp. 1237-1245. type of document: Journal paper/Article number of independent citations: 4 language: English URL |
2018
 from data base, 2023. IX. 13. |
Balatoni T, Mohos A, Papp E, Sebestyen T, Liszkay G, Olah J, Varga A, Lengyel Z, Emri G, Gaudi I, Ladanyi A: Tumor-infiltrating immune cells as potential biomarkers predicting response to treatment and survival in patients with metastatic melanoma receiving ipilimumab therapy, CANCER IMMUNOLOGY IMMUNOTHERAPY 67: (1) pp. 141-151. type of document: Journal paper/Article number of independent citations: 56 language: English URL |
2015
 from data base, 2023. IX. 13. |
Ladányi A: Prognostic and predictive significance of immune cells infiltrating cutaneous melanoma, PIGMENT CELL & MELANOMA RESEARCH 28: (5) pp. 490-500. type of document: Journal paper/Review paper number of independent citations: 113 language: English URL |
2011
 from data base, 2023. IX. 13. |
Ladányi A, Kiss J, Mohos A, Somlai B, Liszkay G, Gilde K, Fejős Zs, Gaudi I, Dobos J, Tímár J: Prognostic impact of B-cell density in cutaneous melanoma, CANCER IMMUNOLOGY IMMUNOTHERAPY 60: (12) pp. 1729-1738. type of document: Journal paper/Article number of independent citations: 182 language: English URL |
2007
 from data base, 2023. IX. 13. |
Ladányi A, Kiss J, Somlai B, Gilde K, Fejős Zs, Mohos A, Gaudi I, Tímár J: Density of DC-LAMP+ mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor, CANCER IMMUNOLOGY IMMUNOTHERAPY 56: (9) pp. 1459-1469. type of document: Journal paper/Article number of independent citations: 204 language: English URL |
2006
 from data base, 2023. IX. 13. |
Dome B, Timar J, Dobos J, Meszaros L, Raso E, Paku S, Kenessey I, Ostoros G, Magyar M, Ladanyi A, Bogos K, Tovari J: Identification and clinical significance of circulating endothelial progenitor cells in human non-small cell lung cancer, CANCER RESEARCH 66: (14) pp. 7341-7347. type of document: Journal paper/Article number of independent citations: 240 language: English URL |
2004
 from data base, 2023. IX. 13. |
Ladányi A, Somlai B, Gilde K, Fejős Z, Gaudi I, Tímár J: T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma, CLINICAL CANCER RESEARCH 10: (2) pp. 521-530. type of document: Journal paper/Article number of independent citations: 106 language: English URL |
| Number of independent citations to these publications: | 937  |
|
|